[Clinical experience on aztreonam].

Author: HayashiS, IwataY, NakamuraH, SekiK

Paper Details 
Original Abstract of the Article :
Aztreonam (AZT), a new monobactam antibiotic, was studied for clinical efficacy in the field of gynecologic infection. AZT was administered at a daily dose of 2 g in 2 divided doses by single shot intravenous injection. The subjects were patients with the following infections: adnexitis (6), pelvic ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/3834142

データ提供:米国国立医学図書館(NLM)

Aztreonam: A New Hope for Gynecological Infections

Gynecological infections can be a challenging and uncomfortable experience. This study investigates the efficacy and safety of aztreonam, a new antibiotic, in treating these infections. It's like discovering a new type of oasis in the desert—researchers are exploring a potential solution to a common problem.

Aztreonam was administered intravenously to patients with various gynecological infections, including adnexitis, pelvic peritonitis, and endometritis. The study found that aztreonam showed good response in a majority of the patients, suggesting it could be a valuable treatment option. This is like finding a spring of fresh water in the middle of a dry desert—aztreonam offers a promising solution to a common challenge.

Aztreonam: A Potential Boon

The study suggests that aztreonam could be a valuable tool in treating gynecological infections. Its efficacy and good safety profile offer hope for patients seeking effective and well-tolerated treatments. Just like a camel finding a plentiful source of water, aztreonam provides a potential respite from the discomfort and inconvenience of gynecological infections.

Moving Forward: A Journey of Discovery

While this study offers encouraging results, further research is needed to fully evaluate the long-term effects of aztreonam. However, this initial exploration provides a promising foundation for continued investigation and development of new treatments for gynecological infections.

Dr. Camel's Conclusion

This study provides a positive initial exploration of aztreonam as a potential treatment for gynecological infections. It highlights the importance of ongoing research and development in finding new and effective solutions to common health challenges. Just as a camel adapts to the ever-changing desert landscape, the field of medicine is constantly evolving to meet the needs of those seeking a better journey toward health and well-being.

Date :
  1. Date Completed 1986-05-23
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

3834142

DOI: Digital Object Identifier

3834142

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.